Brandon Tom
President & Chief Executive Officer
Chicago, Illinois, United States
Professional Overview
Brandon Tom is an accomplished healthcare executive with over 15 years of experience in the pharmaceutical and specialty pharmacy industries. As the President and Chief Executive Officer of Orsini | Rare Disease Pharmacy Solutions, he leverages his deep expertise in the rare disease and specialty pharmacy sectors to drive the company's growth and strategic direction.
Experience Summary
Current Role
In his current role, Brandon is responsible for leading Orsini's overall business strategy, operations, and client partnerships. Under his leadership, the company has strengthened its position as a trusted provider of specialty pharmacy solutions for patients with rare and complex conditions. Brandon's focus on innovation, patient-centric care, and strategic partnerships has been instrumental in driving Orsini's success and industry impact.
Career Progression
Prior to his current role, Brandon held several key leadership positions at Biologics by McKesson, where he served as Vice President and General Manager, as well as Vice President and Chief Commercial Officer. In these roles, he was instrumental in expanding the company's specialty pharmacy and oncology services, while also driving operational excellence and financial performance. Earlier in his career, Brandon held roles at The US Oncology Network and McKesson Specialty Care Solutions, where he gained valuable experience in the areas of corporate strategy, business development, and pharmacy benefit management.
Academic Background
Brandon holds a Bachelor of Science degree in Pharmacy from the University of Illinois at Chicago College of Pharmacy.
Areas of Expertise
- Rare disease and specialty pharmacy operations
- Pharmaceutical industry strategy and business development
- Oncology and value-based care program implementation
- Pharmacy benefit management and payer services
- Leadership and team building in the healthcare sector
Professional Impact
During his tenure at Biologics by McKesson, Brandon played a pivotal role in growing the company's specialty pharmacy and oncology services, resulting in a significant increase in market share and revenue. His strategic initiatives focused on improving patient outcomes, enhancing the provider and payer experience, and driving operational efficiencies. At Orsini, Brandon has continued to build on his success, leveraging his industry expertise to expand the company's rare disease pharmacy solutions and strengthen its position as a leading provider in the specialty pharmacy landscape.
Conclusion
With his extensive industry experience, proven track record of success, and deep commitment to patient-centric care, Brandon Tom is well-positioned to lead Orsini | Rare Disease Pharmacy Solutions into its next phase of growth and innovation. His strategic vision, coupled with his collaborative leadership style, makes him a valuable asset in the rare disease and specialty pharmacy sectors.
